Tech Company Financing Transactions
Aera Therapeutics Funding Round
Arch Venture Partners, GV and Lux Capital invested in a $193 million funding round for Aera Therapeutics. The financing round was announced on 2/17/2023.
Transaction Overview
Company Name
Announced On
2/17/2023
Transaction Type
Venture Equity
Amount
$193,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Boston, MA Undisclosed
USA
Boston, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
With foundational technology developed in the labs of Feng Zhang, Ph.D., of the Broad Institute of MIT and Harvard, and Jason Shepherd, Ph.D., of the University of Utah, Aera was started by a distinguished set of industry leaders and company builders to expand the reach and impact of genetic medicines. Aera's mission is to harness enabling delivery technologies and precision payloads to develop transformative genetic medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Akin Akinc
Co-Founder
Robert Nelsen
Browse more venture capital transactions:
Prev: 2/17/2023: Rhaeos venture capital transaction
Next: 2/17/2023: eDRV venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs